http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021193606-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0931241d9441d023245580a92141bf68 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate | 2021-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_072a26deb23086205b3c011d4592d065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01fdcd5bcab597ab31fed8c3cc64b7f3 |
| publicationDate | 2021-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021193606-A1 |
| titleOfInvention | Mammalian cell preservative solution containing acarbose and dextran |
| abstract | The present invention addresses the problem of providing: a substance which can effectively prevent the decrease in cell survival rate which has been conventionally observed when a mammalian cell is preserved in a liquid, and which is less likely to adversely affect a living body of a mammal when the substance is administered to the mammal in vivo; a mammalian cell preservative solution containing the substance; and others.　When a solution containing acarbose or a salt thereof and dextran or a salt thereof is used for the preservation of a mammalian cell, it becomes possible to effectively prevent the decrease in cell survival rate which has been conventionally observed when the mammalian cell is preserved in a liquid. A mammalian cell preserved in the solution can be directly administered to a mammal in vivo without requiring the transfer of the mammalian cell into another liquid for transplantation. |
| priorityDate | 2020-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.